Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance

British Journal of Cancer

Volumn 76, Issue 7, 1997, Pages 935-938

  Pepper, C ^a   Hoy, T ^b   Bentley, D P ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; Bax; Bcl 2; Drug resistance

Indexed keywords

CHLORAMBUCIL; LIPOCORTIN 5; PROPIDIUM IODIDE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CELL DEATH; CELL SELECTION; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0030752756     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.487     Document Type: Article

References (13)

1. Begleiter A, Lee K, Israels LG, Mowat MRA and Johnston JB (1994) Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacy. Leukemia 8: s103-106
2. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C and Boivin P (1981) A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48: 198-206
3. Cheson BD, Bennett JM, Rai KR, Grever MR, Kay NE, Schiffer CA, Oken MM, Keating MJ, Boldt DH, Kempin SJ and Foon KA (1988) Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored Working Group. Am J Hematol 29: 152-163
4. Collins RJ, Versuchuer LA, Harmon BK, Prentice RI, Pope JH and Kerr JFR (1989) Spontaneous programmed death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. Br J Hematol 71: 343-350
5. 11. Curr Top Microbiol Immunol 194: 307-312
6. Hanada M, Delia D, Aiello A, Stadtmauer E and Reed JC (1993) bcl-2 gene hypomethylation and high level expression in B cell chronic lymphocytic leukemia. Blood 82: 1820-1828
7. Oltvai ZN, Milliman CL and Korsmeyer SJ (1993) bcl-2 heterodimerizes in vitro with a conserved homolog, bax, that accelerates programmed cell death. Cell 74: 609-619
8. Pepper C, Bentley P and Hoy T (1996) Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia. Br J Haematol 95: 513-517
9. Reed JC (1995) bcl-2 family proteins: regulators of chemoresistance in cancer. Toxicol Lett 82/83: 155-158
10. Robertson LE and Plunkett W (1993) Apoptotic cell death in chronic lymphocytic leukemia. Leuk Lymphoma 11 (s2): 71-74
11. Robertson LE, Plunkett W, McConnell K, Keating MJ and McDonnell TJ (1996) Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10: 456-459
12. Thomas A, El Rouby S, Reed JC, Krajewski S, Silber R, Potmesil M and Newcomb EW (1996) Drug induced apoptosis in B cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene 12: 1055-1062
13. Vermes I, Haanen C, Steffens-Nakken H and Reutelingsperger C (1995) A novel assay for apoptosis flow cytometric detection of phosphatidyl serine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184: 39-51